Advanced Search

Home > Journals > Minerva Pneumologica > Past Issues > Minerva Pneumologica 2011 June;50(2) > Minerva Pneumologica 2011 June;50(2):155-8

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA PNEUMOLOGICA

A Journal on Diseases of the Respiratory System

Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus

Frequency: Quarterly

ISSN 0026-4954

Online ISSN 1827-1723

 

Minerva Pneumologica 2011 June;50(2):155-8

    CASE REPORT

Severe out-of-proportion pulmonary hypertension in adult COPD patient and therapy with bosentan

Battaglieri M. 1, Cantoni A. 2

1 Cardiorespiratory Section, Geriatric Department, Istituto Pio Albergo Trivulzio, Milan, Italy
2 Geriatrics, Istituto Pio Albergo Trivulzio, Milan, Italy

Bosentan is a dual endothelin receptor antagonist, indicated for the treatment of pulmonary arterial hypertension (PAH). This paper presents our experience with bosentan therapy in a chronic obstructive pulmonary disease patient with concomitant severe pulmonary hypertension. The therapy implemented led to a gradual reduction in pulmonary artery pressure values and an improvement in a 6-minute walk test. Good tolerance and a safety profile in line with controlled clinical studies were also observed.

language: English


FULL TEXT  REPRINTS

top of page